Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
World Glaucoma Day
New glaucoma research
LCA trial
DSAEK
Events
Laser vision correction
People moves
Survey

We looked at whether virtual reality simulators can improve surgical performance. It is also thought that people who regularly play computer games (PlayStation, Wii, Xbox etc…) often make better surgeons. Would you agree with this?
Novartis

Yes 36%
No 29%
I don’t know – I would need to see further evidence 34%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.

MARCH 10, 2010


World Glaucoma Day
“Glaucoma remains the world's leading cause of irreversible blindness, but 50% of people who have this devastating disease don't know it,” said Dr Clive Midgal, president of the European Glaucoma Society. “In the developing world that figure is likely to be nearer to 90%.”More...
Research set to change how we think about glaucoma in the future
New research is emerging from the Vanderbilt Eye Institute that indicates the first sign of injury in glaucoma occurs in the brain.
A study, published in the Proceedings of the National Academy of Sciences, by David Calkins PhD, director of Research at the Institute and his team reveals that glaucoma is similar to other diseases of the central nervous system. More...
Leber's congenital amaurosis sufferers could benefit from gene therapy trial
Last year a human trial involving administering gene therapy to Leber's congenital amaurosis (LCA) patients produced improvements in 12 children and young adults. The same researchers then conducted an animal study that found that a second injection into the previously untreated eye, was safe and effective with no signs of interference from immune reactions from the earlier injection. More...
Study suggests the potential long-term benefits of DSAEK may outweigh the initial cell loss
One year post-surgery, patients who underwent Descemet's stripping automated endothelial keratoplasty (DSAEK) experienced greater cell loss overall compared to those who underwent penetrating keratoplasty (PKP), according to a new analysis of data collected from the Cornea Donor Study (CDS) Investigator Group's 2008 Specular Microscopy Ancillary Study (SMAS). More...
116th SFO Congress
The Congress of the French Ophthalmology Society, SFO, will take place at the Palais des Congres, 2 place de la Porte Maillot, Paris, France, 8-11 May 2010. More...
New Treatment Results At Winter ESCRS
LEEDS, England -- Ultralase, the vision correction specialist, presented its first set of results for a new treatment, Ultraelite, at the recent Winter meeting of the European Society of Cataract and Refractive Surgeons in Budapest. More...
New CEO at Carl Zeiss
Dr Ludwin Monz is now the new CEO of Carl Zeiss Meditec, having taken over from Dr. Michael Kaschke. Kaschke has been elected back to the Supervisory Board and was appointed its Chairman in a subsequent Supervisory Board meeting. More...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.